Page 28 - Read Online
P. 28

Page 8 of 12                             Khan et al. J Cancer Metastasis Treat 2019;5:71  I  http://dx.doi.org/10.20517/2394-4722.2019.017

               Table 3. Management of hyponatremia [10,19,46]
               Medical therapy Indication                       Dose                      Adverse effects
               Demeclocycline  Euvolemic and hypervolemic   300-600 mg bid           Slow onset of action, acute
                            hyponatremia                                             kidney injury
               Lithium      Euvolemic hyponatremia  600-1800 mg/day                  Narrow therapeutic window,
                                                                                     confusion and somnolence
               Fludrocortisone  Cerebral salt wasting SIAD  0.1-0.3 mg/day           Hypokalemia, hypertension
               NaCl tab     Cerebral salt wasting SIAD  1-3 g/day in divided doses   Non-adherence to therapy for
                                                                                     chronic use
               Urea         Euvolemic hyponatremia  30 g/day                         Lack of palatability, slow onset of
                                                                                     action
               Vaptans      SIAD               Conivaptan                            Dry mouth, increased thirst and
                            hypervolemic hyponatremia  20 mg i.v. bolus over 30 min and then 20 mg i.v. infusion   polyuria;
                                               over 24 h. Infusion rate can be increased to 40 mg daily;   risk of rapid increase in serum
                                               maximum duration of treatment is 4 days.  sodium; liver injury associated
                                               Tolvaptan                             with higher doses; concern for
                                               15 and 30 mg tab for oral use. Maximum dose 60 mg.   increase in mortality
                                               Therapy should be initiated in the hospital with monitoring
                                               of serum sodium
               Hypertonic saline  Euvolemic hyponatremia and  Hypertonic saline 3% 150 mL i.v. bolus over 20 min × 3.   Osmotic demyelination
               3%           hypervolemic hyponatremia  Check serum sodium after every bolus.  syndrome
                                               Hypertonic saline 3% continuous infusion 1-2 mL/kg/h*

               Fluid restriction  Euvolemic and   Fluid restriction (500-1000 mL) includes all fluids including  Rapid correction in case of
                              hypervolemic     intravenous fluids.                   primary polydipsia.
                              hyponatremia     Degree of fluid restriction depends on serum sodium level,  Less likely to be effective if 24 h
                                               urine output and insensible fluid losses.  urine output is < 1500 mL
                                               Fluid restriction to < 500 mL/day of 24 h urine output is
                                               recommended
               Isotonic saline   Hypovolemic   Fluid resuscitation with 0.9% normal saline  Ineffective and potentially
                              hyponatremia                                           dangerous in euvolemic
                                                                                     hyponatremia. Should not
                                                                                     be used in hypervolemic
                                                                                     hyponatremia
               Electrolyte free water  Management of   Electrolyte free water 10 mL/kg over one hour.   Hyponatremia
                              overcorrection   Desmopressin 2 mcg i.v. every 8 h
                                                                         † †
               *Total amount of 3% NaCl to infuse (mL) = (desired change in serum Na × 1000)/ΔNa .  ΔNa (change in serum sodium per liter infused)
                                             #
                    #
               = (513  - serum sodium)/[TBW (L)** + 1].  Amount of sodium (mEq) in 1 L of 3% NaCl. **TBW (L) = weight (kg) × 0.6 (children,
               nonelderly men); 0.5 (nonelderly women, elderly men); or 0.45 (elderly women). SIAD: syndrome of inappropriate antidiuresis; TBW:
               total body water
               used medication to treat SIAD, especially chronic disease, is the tetracycline antibiotic demeclocycline,
                                                                          [34]
               which has the side effect of causing nephrogenic diabetes insipidus . A few of the other side effects of
               demeclocycline include GI intolerance, renal toxicity, and photosensitivity. One should note, however, that
               its onset of action is delayed (typically 5 days or more), so it is not appropriate for the acute management of
               severe SIAD. Urea (available as prescription and over the counter) at a dose of 30-60 g/day has been used to
               induce osmotic diuresis in chronic hyponatremia. Side effects of urea include headache and GI irritation.
               Combining urea with NaHCO , sucrose and citric acid (urea 10 g + NaHCO  2 g + citric acid 1.5 g + sucrose
                                                                               3
                                         3
               200 mg) improves the taste and makes it palatable. Addition of urea to orange juice could also help reduce
               the bitter taste. Fludrocortisone can increase serum sodium up to 5 mEq/L and salt supplementation (NaCl
                                             [35]
               1 g po TID) can also be considered .

               Fluid restriction is preferred in patients with expanded extracellular volume. Intake and output of urine
               should be monitored closely. Free water intake should be 500 mL less than the urine output. Patients with
               reduced extracellular volume and hemodynamic instability require rapid fluid restoration. Extracellular
               volume is restored with i.v. infusion of 0.9% saline or a balanced crystalloid solution. As volume repletion
               suppresses vasopressin release in hypovolemia, close monitoring of serum sodium and urine output
                                                                                             [10]
               is required to avoid hypernatremia in the presence of increased free water clearance . Potassium
               deficiency should be replaced. Since potassium is osmotically active and can be exchanged with sodium,
               overcorrection of sodium is a concern in case of potassium repletion.
   23   24   25   26   27   28   29   30   31   32   33